No Data
No Data
Actinium Pharmaceuticals 2024 Stockholder Meeting Outcomes
Express News | Northstar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
Maxim Group Maintains Actinium(ATNM.US) With Buy Rating, Announces Target Price $5
Stephens Maintains Actinium(ATNM.US) With Buy Rating, Cuts Target Price to $5
Actinium Pharmaceuticals Continues R&D Focus Amid Financial Progress